- Home
- EBS vs PRQR Comparison
EBS vs PRQR Comparison
Compare EBS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBS | PRQR |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.8M | 262.5M |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | EBS | PRQR |
|---|---|---|
| Price | $6.98 | $1.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $11.00 | $7.78 |
| AVG Volume (30 Days) | ★ 1.2M | 652.4K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $742,900,000.00 | N/A |
| Revenue This Year | N/A | $8.25 |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.36 | $1.33 |
| 52 Week High | $14.06 | $3.10 |
Technical Indicators
Market Signals| Indicator | EBS | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 35.26 |
| Support Level | $6.24 | $1.37 |
| Resistance Level | $7.05 | $1.99 |
| Average True Range (ATR) | 0.38 | 0.08 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 52.50 | 20.27 |
Price Performance
Historical ComparisonAbout EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.